Investors Pick Up ITCI Even Cheaper Than Its Secondary Stock Offering
December 28, 2017 at 10:14 AM EST
Looking back to 92 days ago, Intra-Cellular Therapies Inc (ITCI) priced a 9,677,419 share secondary stock offering at $15.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..